Related Experiment Video

Updated: Aug 2, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Reduction of short-term radiation lethality by biological response modifiers given alone or in association with other

J R Maisin1, C Albert, A Henry

  • 1Université Catholique de Louvain, Unité de Radiobiologie et de Radioprotection, Brussels, Belgium.

Radiation Research
|September 1, 1993
PubMed

Insights

Combined chemical protectors enhance survival in X-irradiated mice. WR-2721 and 5-hydroxytryptamine (5-HT) showed significant radioprotection, with synergistic effects observed when combined.

Area of Science:

  • Radiation biology
  • Chemical radioprotection
  • Mammalian radiobiology

Background:

  • X-irradiation poses a significant threat to mammalian survival.
  • Chemical radioprotectors are crucial for mitigating radiation-induced damage.
  • Evaluating combined treatments can optimize radioprotective strategies.

Purpose of the Study:

  • To investigate the efficacy of single and combined chemical protectors against X-ray induced lethality in mice.
  • To identify radioprotectors with superior protective capabilities.
  • To explore synergistic interactions between different radioprotective agents.

Main Methods:

  • Adult male mice were exposed to X-irradiation.
  • Various chemical protectors including 16,16-dimethyl PGE2, cysteine, glucan, glutathione, 5-hydroxytryptamine (5-HT), mercaptoproprionylglycine (MPG), and WR-2721 were administered alone or in combination.
  • Survival rates and dose reduction factors (DRFs) were assessed to evaluate radioprotective efficacy.

Main Results:

  • WR-2721 and 5-HT demonstrated the highest radioprotective effects (DRFs 2.2 and 1.7, respectively).
  • Cysteine and glucan offered moderate protection (DRF 1.4), while PGE2, MPG, and GSH showed minimal protection (DRFs 1.2-1.1).
  • Synergistic radioprotection was observed with combined PGE2 and WR-2721, and also with WR-2721 and 5-HT.

Conclusions:

  • WR-2721 and 5-HT are effective radioprotectors against short-term X-ray lethality.
  • Combining certain radioprotectors, particularly WR-2721 with PGE2 or 5-HT, can yield synergistic protective benefits.
  • Combined radioprotective strategies hold promise for enhancing radiation protection.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors04:53

Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors

Published on: August 25, 2022

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...